NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD.

Saved in:
Bibliographic Details
Title: NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD.
Authors: Curtis LM; 1] Medical Oncology Service, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA [2] Experimental Transplantation and Immunology Branch, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA., Grkovic L; 1] Experimental Transplantation and Immunology Branch, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA [2] Department of Hematology, Clinical Hospital Center Zagreb, University of Zagreb, Zagreb, Croatia., Mitchell SA; Outcomes Research Branch; Division of Cancer Control and Population Sciences, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA., Steinberg SM; Biostatistics and Data Management Section, National Institutes of Health, National Cancer Institute, Rockville, MD, USA., Cowen EW; Dermatology Branch, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA., Datiles MB; National Institutes of Health, National Eye Institute, Bethesda, MD, USA., Mays J; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA., Bassim C; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA., Joe G; Rehabilitation Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Comis LE; Rehabilitation Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Berger A; Pain and Palliative Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Avila D; Experimental Transplantation and Immunology Branch, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA., Taylor T; Experimental Transplantation and Immunology Branch, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA., Pulanic D; Department of Hematology, Clinical Hospital Center Zagreb, University of Zagreb, Zagreb, Croatia., Cole K; Experimental Transplantation and Immunology Branch, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA., Baruffaldi J; Experimental Transplantation and Immunology Branch, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA., Fowler DH; Experimental Transplantation and Immunology Branch, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA., Gress RE; Experimental Transplantation and Immunology Branch, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA., Pavletic SZ; Experimental Transplantation and Immunology Branch, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA.
Source: Bone marrow transplantation [Bone Marrow Transplant] 2014 Dec; Vol. 49 (12), pp. 1513-20. Date of Electronic Publication: 2014 Aug 25.
Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Intramural
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5365
DOI:10.1038/bmt.2014.188